Abstract
This study aimed to investigate fragments derived from human and bovine lactoferrins for ability to inhibit nuclear translocation of HIV-1 integrase. It was shown that human lactoferricin, human lactoferrin 1-11, and bovine lactoferrampin reduced nuclear distribution of HIV-1 integrase. Bovine lactoferrampin could inhibit both the activity and nuclear translocation of HIV-1 integrase. Human lactoferrampin, bovine lactoferricin, and bovine lactoferrin 1-11 had no effect on HIV-1 integrase nuclear translocation. Human lactoferrampin which inhibited the activity of integrase did not prevent its nuclear translocation. Human lactoferricin and lactoferrin 1-11 did not inhibit HIV-1 integrase nuclear translocation despite their ability to attenuate the enzyme activity. The discrepancy between the findings on reduction of HIV-1 activity and inhibition of nuclear translocation of HIV-1 integrase was due to the different mechanisms involved. A similar reasoning can also be applied to the different inhibitory potencies of the milk peptides on different HIV enzymes, i.e., nuclear translocation.
Similar content being viewed by others
References
Włodarski, K. H., Galus, R., Brodzikowska, A., Włodarski, P. K., & Wojtowicz, A. (2014). The importance of lactoferrin in bone regeneration. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 37(217), 65–67.
Brimelow RE, West NP, Williams LT, Cripps AW, Cox AJ. A role for whey-derived lactoferrin and immunoglobulins in the attenuation of obesity-related inflammation and disease? Crit Rev Food Sci Nutr. 2015 [Epub ahead of print].
Redwan, E. M., Uversky, V. N., El-Fakharany, E. M., & Al-Mehdar, H. (2014). Potential lactoferrin activity against pathogenic viruses. Comptes Rendus Biologies, 337(10), 581–595.
Tang, X. S., Shao, H., Li, T. J., Tang, Z. R., Huang, R. L., Wang, S. P., Kong, X. F., Wu, X., & Yin, Y. L. (2012). Dietary supplementation with bovine lactoferrampin-lactoferricin produced by Pichia pastoris fed-batch fermentation affects intestinal microflora in weaned piglets. Applied Biochemistry and Biotechnology, 168(4), 887–898.
Tang, X. S., Tang, Z. R., Wang, S. P., Feng, Z. M., Zhou, D., Li, T. J., & Yin, Y. L. (2012). Expression, purification, and antibacterial activity of bovine lactoferrampin-lactoferricin in Pichia pastoris. Applied Biochemistry and Biotechnology, 166(3), 640–651.
Siqueiros-Cendón, T., Arévalo-Gallegos, S., Iglesias-Figueroa, B. F., García-Montoya, I. A., Salazar-Martínez, J., & Rascón-Cruz, Q. (2014). Immunomodulatory effects of lactoferrin. Acta Pharmacologica Sinica, 35(5), 557–566.
Zuccotti, G. V., Vigano, A., Borelli, M., Saresella, M., Giacomet, V., & Clerici, M. (2007). Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children. International Journal of Antimicrobial Agents, 29(3), 353–355.
Fang, E. F., & Ng, T. B. (2015). A trypsin inhibitor from rambutan seeds with antitumor, anti-HIV-1 reverse transcriptase, and nitric oxide-inducing properties. Applied Biochemistry and Biotechnology, 175(8), 3828–3839.
Yuan, S., Yan, J., Ye, X., Wu, Z., & Ng, T. (2015). Isolation of a ribonuclease with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from Japanese large brown buckwheat seeds. Applied Biochemistry and Biotechnology, 175(5), 2456–2467.
Ng, T. B., Chan, Y. S., Ng, C. C., & Wong, J. H. (2015). Purification and characterization of a lectin from green split peas (Pisum sativum). Applied Biochemistry and Biotechnology, 177(6), 1374–1385.
Yin, C., Wong, J. H., & Ng, T. B. (2014). Recent studies on the antimicrobial peptides lactoferricin and lactoferrampin. Current Molecular Medicine, 14(9), 1139–1154.
Ng, T. B., Lam, T. L., Au, T. K., Ye, X. Y., & Wan, C. C. (2001). Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins. Life Sciences, 69(19), 2217–2223.
Wong, J. H., Liu, Z., Law, K. W., Liu, F., Xia, L., Wan, D. C., & Ng, T. B. (2014). A study of effects of peptide fragments of bovine and human lactoferrins on activities of three key HIV-1 enzymes. Peptides, 62, 183–188.
Li, Y., Xuan, S., Feng, Y., & Yan, A. (2015). Targeting HIV-1 integrase with strand transfer inhibitors. Drug Discovery Today, 20(4), 435–449.
Blanco, J. L., Whitlock, G., Milinkovic, A., & Moyle, G. (2015). HIV integrase inhibitors: a new era in the treatment of HIV. Expert Opinion on Pharmacotherapy, 16(9), 1313–1324.
Greig, S. L., & Deeks, E. D. (2015). Abacavir/dolutegravir/lamivudine single-tablet regimen: a review of its use in HIV-1 infection. Drugs, 75(5), 503–514.
Wainberg, M. A., & Han, Y. S. (2015). Will drug resistance against dolutegravir in initial therapy ever occur? Frontiers in Pharmacology, 6, 90.
Depatureaux A, Mesplède T, Quashie P, Oliveira M, Moisi D, Plantier JC, Brenner B, Wainberg MA. HIV-1 group O resistance against integrase inhibitors. Journal of Acquired Immune Deficiency Syndromes. 2015 [Epub ahead of print]
Seki, T., Suyama-Kagitani, A., Kawauchi-Miki, S., Miki, S., Wakasa-Morimoto, C., Akihisa, E., Nakahara, K., Kobayashi, M., Underwood, M. R., Sato, A., Fujiwara, T., & Yoshinaga, T. (2015). Effects of raltegravir or elvitegravir resistance signature mutations on the barrier to dolutegravir resistance in vitro. Antimicrobial Agents and Chemotherapy, 59(5), 2596–2606.
Smith, R. A., Raugi, D. N., Pan, C., Sow, P. S., Seydi, M., Mullins, J. I., Gottlieb, G. S., & University of Washington-Dakar HIV-2 Study Group. (2015). In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2. Retrovirology, 12, 10.
Zhang, X., Huang, S. Z., Gu, W. G., Yang, L. M., Chen, H., Zheng, C. B., Zhao, Y. X., Wan, D. C., & Zheng, Y. T. (2014). Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation. Chin J Nat Med, 12(3), 186–193.
Wong, J. H., Legowska, A., Rolka, K., Ng, T. B., Hui, M., Cho, C. H., et al. (2011). Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides, 32, 1117–1122.
Gu, W. G., Zhang, X., Ip, D. T., Yang, L. M., Zheng, Y. T., & Wan, D. C. (2014). Discovery of a novel HIV-1 integrase inhibitor from natural compounds through structure based virtual screening and cell imaging. FEBS Letters, 588(18), 3461–3468.
Gu, W. G., Ip, D. T., Liu, S. J., Chan, J. H., Wang, Y., Zhang, X., Zheng, Y. T., & Wan, D. C. (2014). 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor. Chemico-Biological Interactions, 213, 21–27.
Jayappa, K. D., Ao, Z., Yang, M., Wang, J., & Yao, X. (2011). Identification of critical motifs within HIV-1 integrase required for importin α3 interaction and viral cDNA nuclear import. Journal of Molecular Biology, 410(5), 847–862.
Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., & Jans, D. A. (2012). Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. The Biochemical Journal, 443(3), 851–856.
Wagstaff, K. M., Rawlinson, S. M., Hearps, A. C., & Jans, D. A. (2011). An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import. Journal of Biomolecular Screening, 16(2), 192–200.
Debyser, Z., & Christ, F. (2010). On the cell biology of HIV integration from basic research to development of novel antiviral drugs. Verhandelingen-Koninklijke Academie voor Geneeskunde van België, 72, 219–237.
Woodward, C. L., & Chow, S. A. (2010). The nuclear pore complex: a new dynamic in HIV-1 replication. Nucleus, 1(1), 18–22.
Levin, A., Hayouka, Z., Friedler, A., & Loyter, A. (2010). Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein. Nucleus, 1(2), 190–201.
Levin, A., Hayouka, Z., Friedler, A., & Loyter, A. (2010). Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells. Nucleus, 1(5), 422–431.
Ao, Z., Danappa Jayappa, K., Wang, B., Zheng, Y., Kung, S., Rassart, E., Depping, R., Kohler, M., Cohen, E. A., & Yao, X. (2010). Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication. Journal of Virology, 84(17), 8650–8663.
Deprez, E., Barbe, S., Kolaski, M., Leh, H., Zouhiri, F., Auclair, C., Brochon, J. C., Le Bret, M., & Mouscadet, J. F. (2004). Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro. Molecular Pharmacology, 65(1), 85–98.
He, Q. Q., Zhang, X., Yang, L. M., Zheng, Y. T., & Chen, F. (2013). Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(4), 671–676.
Suedee, A., Tewtrakul, S., & Panichayupakaranant, P. (2014). Anti-HIV-1 integrase activity of Mimusops elengi leaf extracts. Pharmaceutical Biology, 52(1), 58–61.
Li, B. W., Zhang, F. H., Serrao, E., Chen, H., Sanchez, T. W., Yang, L. M., Neamati, N., Zheng, Y. T., Wang, H., & Long, Y. Q. (2014). Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. Bioorganic & Medicinal Chemistry, 22(12), 3146–3158.
Acknowledgments
We gratefully acknowledge the award of an HMRF research grant (reference no. 12110672) from Food and Health Bureau, Hong Kong, and a research grant (no. 81471927) from National Natural Science Foundation of China. We thank Professor S.A. Chow (School of Medicine, UCLA) for his gift of the recombinant HIV-1 integrase clone.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Wang, W.Y., Wong, J.H., Ip, D.T.M. et al. Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase. Appl Biochem Biotechnol 179, 1202–1212 (2016). https://doi.org/10.1007/s12010-016-2059-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-016-2059-y